Tower Research Capital LLC (TRC) - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$6
-99.4%
56,548
+664.7%
0.00%
Q3 2022$1,000
-80.0%
7,395
-18.6%
0.00%
Q1 2022$5,000
+150.0%
9,086
+254.2%
0.00%
Q4 2021$2,0002,565
+2465.0%
0.00%
Q3 2021$0
-100.0%
100
-99.4%
0.00%
-100.0%
Q2 2021$31,000
-77.5%
16,992
-75.8%
0.00%
-50.0%
Q1 2021$138,000
+263.2%
70,086
+129.1%
0.00%
+100.0%
Q4 2020$38,000
-82.2%
30,586
-74.3%
0.00%
-50.0%
Q3 2020$214,000
+4.4%
118,824
+387.3%
0.00%
-75.0%
Q2 2020$205,000
+10150.0%
24,383
+5995.8%
0.01%
Q4 2019$2,000
-90.0%
400
-90.0%
0.00%
-100.0%
Q3 2019$20,000
+1900.0%
4,008
+3908.0%
0.00%
Q2 2019$1,000
-96.0%
100
-97.9%
0.00%
-100.0%
Q2 2018$25,000
+212.5%
4,857
+314.8%
0.00%0.0%
Q4 2017$8,000
-50.0%
1,171
-45.9%
0.00%0.0%
Q3 2017$16,000
+220.0%
2,164
+167.2%
0.00%0.0%
Q2 2017$5,000
+25.0%
810
+57.0%
0.00%
Q4 2016$4,000
+300.0%
516
+10.3%
0.00%
Q1 2016$1,000
-91.7%
468
-93.9%
0.00%
-100.0%
Q4 2015$12,0007,644
+4589.6%
0.00%
Q3 2015$0
-100.0%
163
-82.4%
0.00%
Q2 2015$3,0009240.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders